| Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases CY Ok, KP Patel, G Garcia-Manero, MJ Routbort, B Fu, G Tang, ... Leukemia research 39 (3), 348-354, 2015 | 145 | 2015 |
| TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases CY Ok, KP Patel, G Garcia-Manero, MJ Routbort, J Peng, G Tang, ... Journal of hematology & oncology 8, 1-8, 2015 | 129 | 2015 |
| Characterization of SGN-CD123A, a potent CD123-directed antibody–drug conjugate for acute myeloid leukemia F Li, MK Sutherland, C Yu, RB Walter, L Westendorf, J Valliere-Douglass, ... Molecular cancer therapeutics 17 (2), 554-564, 2018 | 92 | 2018 |
| Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution G Tang, L Zhang, B Fu, J Hu, X Lu, S Hu, A Patel, M Goswami, JD Khoury, ... American journal of hematology 89 (8), 813-818, 2014 | 84 | 2014 |
| CRLF2-positive B-cell acute lymphoblastic leukemia in adult patients: a single-institution experience S Konoplev, X Lu, M Konopleva, N Jain, J Ouyang, M Goswami, ... American journal of clinical pathology 147 (4), 357-363, 2017 | 62 | 2017 |
| Microbial metabolism of 2-chlorophenol, phenol and ρ-cresol by Rhodococcus erythropolis M1 in co-culture with Pseudomonas fluorescens P1 M Goswami, N Shivaraman, RP Singh Microbiological Research 160 (2), 101-109, 2005 | 61 | 2005 |
| Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems B Fu, JM Jaso, RL Sargent, M Goswami, S Verstovsek, LJ Medeiros, ... Modern pathology 27 (5), 681-689, 2014 | 59 | 2014 |
| CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course Z Hu, Y Sun, EJ Schlette, G Tang, S Li, J Xu, CC Yin, KH Young, KP Patel, ... Modern Pathology 31 (2), 327-336, 2018 | 55 | 2018 |
| Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation J Peng, Z Zuo, B Fu, Y Oki, G Tang, M Goswami, P Priyanka, T Muzzafar, ... European journal of haematology 96 (1), 65-71, 2016 | 53 | 2016 |
| High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome AHG Cleven, V Nardi, CY Ok, M Goswami, P Dal Cin, Z Zheng, AJ Iafrate, ... Modern Pathology 28 (4), 552-563, 2015 | 52 | 2015 |
| Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases EY Loo, LJ Medeiros, TN Aladily, D Hoehn, R Kanagal-Shamanna, ... The American Journal of Surgical Pathology 37 (8), 1290-1297, 2013 | 49 | 2013 |
| Comparison of multiparameter flow cytometry immunophenotypic analysis and quantitative RT-PCR for the detection of minimal residual disease of core binding factor acute myeloid … J Ouyang, M Goswami, J Peng, Z Zuo, N Daver, G Borthakur, G Tang, ... American journal of clinical pathology 145 (6), 769-777, 2016 | 46 | 2016 |
| The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid … J Ouyang, M Goswami, G Tang, J Peng, F Ravandi, N Daver, M Routbort, ... American journal of hematology 90 (6), 504-510, 2015 | 41 | 2015 |
| CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis W Zheng, LJ Medeiros, KH Young, M Goswami, L Powers, HH Kantarjian, ... Leukemia & lymphoma 55 (3), 624-627, 2014 | 41 | 2014 |
| Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma JR Wang, M Montierth, L Xu, M Goswami, X Zhao, G Cote, W Wang, P Iyer, ... JCO Precision Oncology 6, e2100504, 2022 | 30 | 2022 |
| Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study W Zheng, D Liu, X Fan, L Powers, M Goswami, Y Hu, P Lin, LJ Medeiros, ... Cytometry Part B: Clinical Cytometry 84 (4), 222-228, 2013 | 28 | 2013 |
| The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes B Fu, CY Ok, M Goswami, W Xei, JM Jaso, T Muzzafar, C Bueso-Ramos, ... Annals of hematology 92, 1335-1343, 2013 | 26 | 2013 |
| Ten-day decitabine with venetoclax (DEC10-VEN) in acute myeloid leukemia: updated results of a phase II trial A Maiti, CD DiNardo, CR Rausch, JE Cortes, N Pemmaraju, NG Daver, ... Blood 134, 2637, 2019 | 21 | 2019 |
| Tetraploidy/near-tetraploidy acute myeloid leukemia L Huang, SA Wang, C DiNardo, S Li, S Hu, J Xu, W Zhou, M Goswami, ... Leukemia Research 53, 20-27, 2017 | 17 | 2017 |
| A multimodality work‐up of patients with Hypereosinophilia Z Hu, PC Boddu, S Loghavi, RN Miranda, M Goswami, LJ Medeiros, ... American journal of hematology 93 (11), 1337-1346, 2018 | 16 | 2018 |
